Thu, Sep 18, 2014, 1:28 AM EDT - U.S. Markets open in 8 hrs 2 mins


% | $
Quotes you view appear here for quick access.

Geely Automobile Holdings Ltd. Message Board

toegar2000 7 posts  |  Last Activity: Sep 12, 2014 5:36 PM Member since: Feb 10, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    C. Diff vaccine....

    by rosettawest Aug 30, 2014 10:00 AM
    toegar2000 toegar2000 Sep 12, 2014 5:36 PM Flag

    Synthetic Biologics Inc. (SYN) a small biotech who is working with PFE is also developing a drug to combat C. Diff. They are also working on an MS drug. Good luck.

    Sentiment: Hold

  • toegar2000 by toegar2000 Aug 31, 2014 4:37 PM Flag

    This baby is going higher this coming week. Glad I got in!!!!

    Sentiment: Strong Buy

  • Reply to

    229600 share block up @ $1.70

    by toegar2000 Aug 12, 2014 3:53 PM
    toegar2000 toegar2000 Aug 12, 2014 4:19 PM Flag

    The bid came up on my screen a few minutes before the close.

    Sentiment: Strong Buy

  • Reply to

    229600 share block up @ $1.70

    by toegar2000 Aug 12, 2014 3:53 PM
    toegar2000 toegar2000 Aug 12, 2014 3:58 PM Flag

    They bought in just now @ $1.71 for 208600 shares. Someone's putting their $ up for a big gain.

    Sentiment: Strong Buy

  • Reply to

    229600 share block up @ $1.70

    by toegar2000 Aug 12, 2014 3:53 PM
    toegar2000 toegar2000 Aug 12, 2014 3:54 PM Flag

    That's a BID by the way!

    Sentiment: Strong Buy

  • Someone put a 229600 share block up @ $1.70. $390,320 isn't chump change. Somethings up!

    Sentiment: Strong Buy

  • toegar2000 by toegar2000 Aug 1, 2014 10:17 AM Flag


    To improve the lives of patients suffering from multiple sclerosis.

    UCLA MS Clinical Services, an integral part of the overall Multiple Sclerosis Program at UCLA, serves the neurologist or primary care physician's referral needs by:

    Providing a full range of diagnostic services for patients experiencing symptoms with no definitive diagnosis
    Providing a second opinion for patients who have been diagnosed with multiple sclerosis
    Providing the referring neurologist with an individualized treatment plan for the MS patient with a confirmed diagnosis
    Providing access to clinical trials in MS

    Program Highlights

    MS patients are seen by dedicated specialists with decades of combined experience and/or fellowship training in the diagnosis and treatment of this difficult disease. UCLA is a designated MS Comprehensive Care Center.

    Rhonda Voskuhl, M.D., Jack H. Skirball Chair in MS Research and Director of the M.S. Program at UCLA, is an internationally recognized expert in MS, focusing on translational work by moving from the bedside (clinical observations) to the bench (research) to the bedside (novel clinical trials). Four translational clinical trials have been conducted by Dr. Voskuhl based on work originating in her research lab, with two of these trials involving many sites across the U.S. See UCLA Dept of Neurology?s MS Research website for more information. In 2013, Dr. Voskuhl was one of five finalists for the Barancik Prize from the National MS Society, an award recognizing the Most Innovative MS Researcher in the World. Dr. Voskuhl's patient care focus is giving second opinions on diagnosis of complex cases as well as on major changes in MS treatment management. She also trains post doctoral fellows, graduate students and undergraduates on clinical MS.

    Barbara Giesser, M.D., clinical director of UCLA MS Clinical Services.

0.389+0.003(+0.78%)Sep 17 3:31 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.